This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sirotnak, F. M. Articles by O'Leary, D. F. Search for Related Content PubMed PubMed Citation Articles by Sirotnak, F. M. Articles by O'Leary, D. F.

The Issues of Transport Multiplicity and Energetics Pertaining to Methotrexate Efflux in L1210 Cells Addressed by an Analysis of Cis and Trans Effects of Inhibitors¹

Memorial Sloan-Kettering Cancer Center, New York, New York 10021

Studies are described addressing the controversial issue of the multiplicity of efflux routes for [³H]MTX in L1210 cells. We examined efflux multiplicity under conditions that do and do not maintain cellular ATP at the physiological level. In ATP-replete cells, the results delineate a probenecid-, bromosulfophthalein-, and verapamil-inhibitable route that accounts for nearly 90% of [³H]MTX efflux. Efflux of [³H]MTX by this route is inhibited by bromosulfophthalein in the trans orientation only, inhibited by probenecid only when present simultaneously in the cis and trans orientation and inhibited by verapamil only in the cis orientation. The remaining efflux of this folate analogue in ATP-replete cells appears to be mediated by the one-carbon, reduced folate system (MTX influx route), in that it is not inhibited by bromosulfophtalein or verapamil but is inhibited by the N-hydroxysuccinimide ester of MTX, a specific inhibitor of MTX influx, and a 10-fold higher concentration of probenecid than that required to inhibit ATP-dependent efflux. Under these conditions, MTX did not trans-stimulate [³H]MTX efflux. Also, no evidence was obtained for a putative bromosulfophthalein-insensitive, probenecid-inhibitable route for [³H]MTX efflux. In cells depleted to the extent of 90–95% of their ATP by 60-min incubation in medium in the absence of D-glucose and with 10 mM sodium azide, overall efflux of [³H]MTX was markedly reduced and appears to be mediated solely by the MTX influx route. Influx of [³H]MTX was both cis and trans inhibited by probenecid, and efflux under these conditions was markedly inhibited by the N-hydroxysuccinimide ester of MTX and trans-stimulated by MTX. Over-all, the results of these studies are consistent with a model for methotrexate transport in L1210 cells derived [Dembo et al., J. Membrane Biol., 78: 9–17, 1984] in the authors' laboratory based solely upon a kinetic analysis of [³H]MTX influx and efflux in ATP-replete and depleted L1210 cells. As such, these new results identify a single ATP-dependent efflux route as the bromosulfophthalein-, probenecid-, and verapamil-inhibitable route in L1210 cells under conditions that maintain ATP levels at maximum.

¹ Supported in part by Grants CA 08748 and CA 46673 from the National Cancer Institute, Grant CH-26 from the American Cancer Society, and the Elsa U. Pardee Foundation.

² To whom requests for reprints should be addressed, at Laboratory for Molecular Therapeutics, Memorial Sloan-Kettering Cancer Center, New York, NY 10021.

Received 8/30/90. Accepted 12/20/90.

This article has been cited by other articles:

				E. L. Volk and E. Schneider Wild-Type Breast Cancer Resistance Protein (BCRP/ABCG2) is a Methotrexate Polyglutamate Transporter Cancer Res., September 1, 2003; 63(17): 5538 - 5543. [Abstract] [Full Text] [PDF]

				E. L. Volk, K. M. Farley, Y. Wu, F. Li, R. W. Robey, and E. Schneider Overexpression of Wild-Type Breast Cancer Resistance Protein Mediates Methotrexate Resistance Cancer Res., September 1, 2002; 62(17): 5035 - 5040. [Abstract] [Full Text] [PDF]

				J. Worm, A. F. Kirkin, K. N. Dzhandzhugazyan, and P. Guldberg Methylation-dependent Silencing of the Reduced Folate Carrier Gene in Inherently Methotrexate-resistant Human Breast Cancer Cells J. Biol. Chem., October 19, 2001; 276(43): 39990 - 40000. [Abstract] [Full Text] [PDF]

				N. Z. Khokhar, Y. She, V. W. Rusch, and F. M. Sirotnak Experimental Therapeutics with a New 10-Deazaaminopterin in Human Mesothelioma: Further Improving Efficacy through Structural Design, Pharmacologic Modulation at the Level of MRP ATPases, and Combined Therapy with Platinums Clin. Cancer Res., October 1, 2001; 7(10): 3199 - 3205. [Abstract] [Full Text] [PDF]

				F. M. Sirotnak, H. G. Wendel, W. G. B. Bornmann, W. P. Tong, V. A. Miller, H. I. Scher, and M. G. Kris Co-administration of Probenecid, an Inhibitor of a cMOAT/MRP- like Plasma Membrane ATPase, Greatly Enhanced the Efficacy of a New 10-Deazaaminopterin against Human Solid Tumors in Vivo Clin. Cancer Res., September 1, 2000; 6(9): 3705 - 3712. [Abstract] [Full Text]

				E. L. Volk, K. Rohde, M. Rhee, J. J. McGuire, L. A. Doyle, D. D. Ross, and E. Schneider Methotrexate Cross-Resistance in a Mitoxantrone-selected Multidrug-resistant MCF7 Breast Cancer Cell Line Is Attributable to Enhanced Energy-dependent Drug Efflux Cancer Res., July 1, 2000; 60(13): 3514 - 3521. [Abstract] [Full Text]

				J. H. Hooijberg, H. J. Broxterman, M. Kool, Y. G. Assaraf, G. J. Peters, P. Noordhuis, R. J. Scheper, P. Borst, H. M. Pinedo, and G. Jansen Antifolate Resistance Mediated by the Multidrug Resistance Proteins MRP1 and MRP2 Cancer Res., June 1, 1999; 59(11): 2532 - 2535. [Abstract] [Full Text] [PDF]

				K. Roy, B. Tolner, J. H. Chiao, and F. M. Sirotnak A Single Amino Acid Difference within the Folate Transporter Encoded by the Murine RFC-1 Gene Selectively Alters its Interaction with Folate Analogues. IMPLICATIONS FOR INTRINSIC ANTIFOLATE RESISTANCE AND DIRECTIONAL ORIENTATION OF THE TRANSPORTER WITHIN THE PLASMA MEMBRANE OF TUMOR CELLS J. Biol. Chem., January 30, 1998; 273(5): 2526 - 2531. [Abstract] [Full Text] [PDF]

				M. J. Spinella, K. E. Brigle, E. E. Sierra, and I. D. Goldman Distinguishing between Folate Receptor-alpha-mediated Transport and Reduced Folate Carrier-mediated Transport in L1210 Leukemia Cells J. Biol. Chem., April 7, 1995; 270(14): 7842 - 7849. [Abstract] [Full Text] [PDF]

				M. Saxena and G. B. Henderson ATP-dependent Efflux of 2,4-Dinitrophenyl-S-glutathione J. Biol. Chem., March 10, 1995; 270(10): 5312 - 5319. [Abstract] [Full Text] [PDF]